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Abstract: Over the second half of 20
th century much research on lipogenesis has been conducted, especially focused on 
increasing the production efficiency and improving the quality of animal derived products. However, many diferences are 
observed in the physiology of lipogenesis between species. Recently, many studies have also elucidated the involvement 
of numerous genes in this procedure, highlighting diferences not only at physiology but also at the molecular level. The 
main scope of this review is to point out the major differences between ruminant and non ruminant species, that are ob-
served in key regulatory genes involved in lipogenesis. Human is used as a central reference and according to the find-
inggs, main differences are analysed. These findings could serve not only as basis for understanding the main physiology 
of lipogenesis and further basic research, but also as a basis for any animal scientist to develop new concepts and methods 
for use in improving animal production and modern genetic improvement. 
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1. INTRODUCTION  
  During the past decades consumers have started seeking 
animal products of low fat content and of high and consistent 
quality. This fact has led animal production to invest in re-
search aimed at the study of metabolism and the procedure 
of lipogenesis.  
  Lipogenesis occurs in all vertebrate species and entails a 
number of metabolic steps that lead to the synthesis of fatty 
acids and subsequent triglyceride synthesis. The major sites 
that lipogenesis generally takes place are the intestinal mu-
cosal cells, the liver, the adipose tissue and in lactating 
mammals the mammary gland. The intestinal mucosal cells 
have as a main role to handle and use the fatty acids ab-
sorbed from the diet. In contrast, the other three tissues are 
responsible for the de novo synthesis of fatty acids, using as 
a prior molecule the acetyl-coA derived from the catabolism 
of carbohydrates and to a lesser extent the amino acids. 
  In ruminants the predominant anatomic site for lipogene-
sis is adipose tissue [1]. Most of the dietary carbohydrate is 
fermented to acetate, propionate and butyrate in the rumen, 
so liver metabolism is dominated by glucose synthesis while 
acetate is the major lipogenic precursor in adipose tissue and 
in mammary gland during lactation [2]. On the contrary, in 
human and birds the liver is considered as the major site for 
lipogenesis, whereas pig seems to resemble the ruminants 
with respect to lipogenesis. In rodents and rabbit both liver 
and adipose tissue are important for synthesizing fatty [3,4]. 
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  The main key role of adipose tissue is the control of en-
ergy balance, providing the appropriate “fuel” in the form of 
fatty acids, when it is required. Adipose tissue can also offer 
a mechanical role and a thermal insulation [5]. This is par-
ticularly evident in the case of blubber observed in marine 
species [6]. Moreover, Cousin et al. [7] have reported the 
involvement of adipose tissue in inflammatory processes, as 
preadipocytes observed to act as macrophage-like cells. In 
addition to all these, adipose tissue plays an important role in 
glucose homeostasis. The discovery of leptin [8], a cytokine-
like factor secreted from mature adipocytes, demonstrated 
that adipose tissue can works also as an endocrine and secre-
tory organ [2,5,6]. Recently, many other substances apart 
from leptin were found to be secreted from adipose tissue 
(Fig. 1), playing an important role in the regulation of energy 
balance and other physiological processes [see 2, 6, 9, 10]. 
Thus, the role of adipose tissue is far beyond the simple role 
of fat storage, ranging from the metabolic regulation to the 
physiological homeostasis.  
  In ruminants, apart from the above roles, adipose tissue 
growth, which results from a change in either fat cell size 
(hypertrophy) or fat cell number (hyperplasia) or both [11], 
can affect the economic return of the production system. 
Excess fat deposits influence negatively the grading of car-
casses [11, 12]. Moreover, the high intramuscular fat deposi-
tion (marbling) is a desired characteristic of meat quality 
[13]. In addition, the dynamics of adipose tissue metabolism, 
especially during puberty or during the last stage of preg-
nancy, is related to health status (i.e. ketosis or toxaemia) 
and future reproductive and lactating performance [14]. 
Thus, the control of fatty acid synthesis (lipogenesis) is of 
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  Several studies have been conducted in many eutherian 
species (human / animals) investigating aspects and factors 
influencing or controlling lipogenesis (diet, hormones, stress, 
age, breed etc.). The advent of new technologies at molecu-
lar level has elucidated many genes implicated in the com-
plicated procedure of lipogenesis, providing new insights 
into understanding its function and offering the possibility to 
explore new perspectives in studies of lipogenesis. The main 
aim of this review is to elucidate any difference existing in 
the key regulatory genes involved in the de novo synthesis of 
fatty acids between ruminants (a group of mammals with a 
different metabolic pathway and main anatomic site for lipo-
genesis) and non-ruminant species, sketching out, at the 
same time, possible future expectations based on the above 
field. As a base line human species is set and according to 
this any discrepancies are further discussed. 
2. LIPOGENESIS: A COMPLEX BIOCHEMICAL 
PROCEDURE IMPELLED BY MULTI-FACTORIAL 
STIMULI  
2.1. Pathway 
  The metabolic pathways involved in the synthesis of fatty 
acids and their subsequent esterification to form triacyl-
glycerols are well established and have been studied in con-
siderable detail [15, 16]. Fatty acids are synthesized by an 
extramitochondrial system [17], which is responsible for the 
complete synthesis of palmitate from acetyl-CoA in the cyto-
sol. A well recognized and major metabolic difference be-
tween the ruminant and non-ruminant is the failure of carbon 
from glucose to contribute to fatty acid synthesis within the 
tissues of a ruminant, including mammary gland. This phe-
nomenon is usually account for by the low activity of ATP 
citrate lyase and malate dehydrogenase. In ruminants the 
most of glucose is derived from gluconeogenesis [18], while 
acetate, and in a less portion propionate and butyrate, which 
are the main fuel molecules produced in the rumen, com-
promising the precursors for the initiation of lipogenesis in 
both adipose tissue and mammary gland.  
  Acetate is transformed into pyruvate and then, via oxida-
tion within mitochondria, is further transformed into acetyl-
CoA. Acetyl-CoA is the principal building block of fatty 
acids. Fig. (2) displays the major biosynthetic steps involved 
in the formation of fatty acids. The biosynthesis of palmitate 
is catalyzed by the complex of fatty acid synthase (FAS). 
The overall reaction catalyzed by FAS can be summarized 
by the equation:  
Acetyl-CoA + 7Malonyl-CoA +14NADPH +14H
+ Palmi-
tate + 14NADP + 8CoA + 7CO2 
+ + 6H2O 
  The malonyl-CoA that is required is derived from the 
acetyl-CoA under the catalytic action of acetyl-CoA car-
boxylase. It should be noted that in small ruminants 
propionyl-CoA can be used in place of acetyl-CoA as the 
primer molecule for fatty acids synthesis giving rise to the 
odd-numbered of fatty acids [13, 19]. 
  From the above reaction it is obvious that the biosynthe-
sis of fatty acids apart from carbon substrate requires also 
considerable amounts of reducing equivelants in the form of 
NADPH for the reduction of acetyl-CoA to fatty acids [20, 
21]. The principal enzymes that are responsible for the 
NADPH production in ruminants are: i) glucose 6-phosphate 
dehydrogenase (G6PD), ii) 6-phosphogluconate dehydro-
genase (6PGD), iii) cytosolic NADP malate dehydrogenase 
(malic enzyme, ME1) and iv) cytosolic NADP isocitrate 
dehydrogenase (IDH1)  
  The first two enzymes (G6PD and 6PGD) comprise the 
major sources of NADPH and they are involved in the pen-
tose phosphate shunt. Specifically, G6PD catalyzes the first 
committed reaction, while 6PGD catalyzes the final reaction 
in the oxidative pentose pathway (Fig. 2). Approximately the 
30 to 50% of the required NADPH comes from the catalytic 
action of G6PD and 6PGD [12, 22]. In cow and sheep this 
percentage can reach the 50-100% and 30-100%, respec-
tively [13]. NADP malate dehydrogenase is generally 
thought to have a minor role in NADPH production in rumi-
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sequence of citrate oxaloacetate malate pyruvate se-
quence not significant in ruminants [13]. Concerning IDH, in 
ruminants it has been suggested that it is responsible for pro-
viding the rest of NADPH not produced by the pentose 
phosphate shunt [1, 13]. Palmitate is then used as the sub-
strate for further synthesis of fatty acids through the proce-
dures of elongation and/or desaturation, which are taking 
place in the endoplasmic reticulum (ER) via the interaction 
of many catalytic enzymes (i.e. reductases, desaturases, 
elongases). 
2.2. Factors Affecting Lipogenesis 
  Lipogenesis belongs to the group of quantitative traits. 
This means that apart from factors concerning the genetic 
make-up of the animal, many other non-genetic factors be-
longed to the so-called “wider micro/macro environment” 
can affect the procedure of lipogenesis.  
  A genotype is fixed at the moment of conception. Once it 
receives its genes, which are the direct link between parent 
and offspring, it is landed with those genes for life. How-
ever, it should be noted that different sets of genes are 
switched on and off under different environments. Breed has 
been used to provide a possible explanation of the observed 
difference in metabolic rates and in adipose tissue size in a 
variety of studies. The differences observed in fat distribu-
tion among several breeds of sheep and goats [for review see 
23] are likely related to genetic differences in the metabolic 
regulators resulting in different lipogenic activity [12]. Meat 
type breeds have the ability to deposit more fat than the dairy 
breeds. According to Vernon [13] both subcutaneous and 
perirenal adipose tissue from beef cattle had greater rate of 
fatty acids synthesis than the same type of adipose tissue 
from dairy cattles of the same age and weight.  
  However, differences can also observed in breeds of the 
same productive type. For example, Panopoulou et al. [24] 
comparing two Greek dairy breeds, observed that the peri-
renal adipose tissue of the Karagouniki breed was more de-
veloped in respect with Chios breed at the same age and 
weight. Differences were also observed by the same authors, 
in the enzymatic activities of NADPH generating dehydro-
genases in the adipose tissue of the above breeds, indicating 
the different fatness between the two breeds.  
  Analyzing the “wider environmental” factors, lipogenesis 
in all species is known to be subjected to acute homeostatic 
and to chronic homeorhetic control [25-27]. The former in-
cludes a variety of factors involving hormones (i.e. insulin) 
and locally produced modulators (i.e. prostaglandins). Ho-
meorhetic control is concerned with modulation of lipid me-
tabolism of tissues to meet the changing needs of a particular 
physiological, nutritional or pathologic state. The recently 
discovery that adipose tissue can produce many others mole-
cules apart from fatty acids (i.e. leptin, TNFa, resistin) led to 
the formulation that lipogenesis is also susceptible to a third 
type of control called autonomic. This type of control refers 
to factors produced within the adipose tissue controlling 
lipogenesis and is concerned with modulating the mass of 
adipose tissue to meet the needs of animals [2]. However, 
analyzing further this topic is out of the purpose of this re-
view.  
3. FOCUSING ON MOLECULAR LEVEL 
  In order to be achieved either the homeostatic or ho-
meorhetic and autonomic control, stimulation of the genes 
involved in the procedure of the de novo synthesis of fatty 
acids should be firstly take place. Thus, lipogenic gene’s 
expression is the first level for elucidating new mechanisms 
of control. Developments in molecular techniques have al-
lowed elaborated studies of the genes, bringing to light novel 
levels of complexity concerning the regulation of lipogene-
sis. The scope of this section is the review of the advances in 
the main lipogenic genes isolated in ruminants and non ru-
minant mammalian species (especially human, mouse, rat), 
elucidating, in the possible extent due to data limitation, the 
complexities that have aroused. Specific attention is given to 
the major lipogenic genes encoding acetyl-CoA carboxylase, 
fatty acid synthase and NADP-dependent dehydrogenases.  
3.1. Acetyl-CoA Carboxylase 
  Acetyl-CoA carboxylase (ACC), the rate-limiting en-













Fig. (2). Ovine ACC transcripts formation [25]. Ovine ACC gene consists of three distinct promoter regions which give rise to different tran-
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ing cytoplasmic enzyme that catalyses the ATP-dependent 
carboxylation of acetyl-CoA to form malonyl-CoA, the acti-
vated donor of two carbon units for fatty acid chain elonga-
tion by the enzyme fatty acid synthase. Two isoenzymes of 
ACC, termed ACC- and –, transcribed from separate 
genes and with different functions have been described [27-
30].  
 ACC- gene gives rise to a 265 KDa enzyme that is 
ubiquitously expressed. Its expression is highly inducible in 
the major lipogenic tissues such as adipose tissue, liver and 
lactating mammary gland. Concerning ACC- gene, it en-
codes a 275-280 KDa protein and is expressed predomi-
nately in tissues that utilize fatty acids as an energy source, 
i.e. heart and skeletal muscle [30-32]. Interestingly, it does 
not appear to be expressed to any appreciable extent in adi-
pose tissue or other lipogenic tissue.  
  Herein, the ACC- is discussed as it is involved in the de 
novo synthesis of fatty acids. ACC- has been cloned and 
characterized in depth in many species including  human 
[33], rat [34], cattle [35], chicken [36], yeast [37] and bacte-
ria [38]. In all cases the translated product is a 2,346 aa pro-
tein with high similarity among species. Table 1 summarizes 
the main differences among the characterized species.  
  In sheep there is no exception from the rule, according to 
Barber and Travers [39]. The ovine ACC cDNA, encodes a 
protein of 2,346 aa residues with a calculated molecular 
mass of 265 KDa. The deduced amino acid residues se-
quence shows a well conserved protein among mammals and 
other species. Moreover, heterogeneity in the 3’ UTR was 
observed, revealing in two transcripts with 2,065 or 1,635 nt. 
This is due to the differential use of two polyadenylation 
sites. Concerning the region of 5’ UTR, similar to all deter-
mined species, four identified clones have been described, 
falling into two classes of transcripts; Class 1, which differ 
in the presence or absence of a 47 nucleotide sequence and 
Class 2, which differ in the presence or absence of a 61 nu-
cleotide and / or a 47 nucleotide sequence [40]. Class 1 tran-
scripts are found in liver and adipose tissue under lipogenic 
conditions, while Class 2 transcripts are found in all tissues 
and are increased in abundance in mammary gland during 
lactation. The same characteristics are also reported for the 
bovine counterpart [35]. 
 The  ACC- isoforms are products of two promoters, P1 
and PII, which are acting in a tissue-specific manner. The 
use of these promoters results in the generation of the ob-
served heterogeneous population of mRNA containing, the 
primary coding exon (Fig. 2). In contrast to other species, 
Barber and Travers [29] reported the presence of a novel 
transcript of ACC- gene in the mammary gland. According 
to the authors, this transcript (termed 5A/ E5A-type tran-
script) is a product of a third promoter (PIII) resided inside 
intron 5 [35, 40] and differs from the previously described 
mRNAs in that exon 5 is replaced by a 424 nt sequence rep-
resenting the 5’ terminus of the mRNA [40]. Additionally, 
its expression is tissue-restricted; it is undetectable in adi-
pose tissue, spleen, heart and skeletal muscle, while is pre-
sent in liver, kidney, lung, brain, and is observed in very 
high levels in lactating mammary gland.  
  According to mRNA measurements of ACC-a tran-
scripts, in subcutaneous adipose tissue from non lactating 
sheep approximately the 60% is derived from PI activity, 
while lactation results in a 88% reduction in total PI tran-
scripts. In the contrary, it reduces the total level of transcripts 
PII by only 50% [41]. This transcript diversity, according to 
Travers and Barber [41] is due to insulin-glucocorticoid in-
teractions in ovine adipose tissue. Concerning PIII promoter 
activity, expression of E5A transcripts are increased 15-fold 
relative to mammary tissue of non-pregnant non-lactating 
animals. Generally, E5A mRNAs contribute less than 10% 
of the total ACC- mRNA in most tissues that is expressed, 
but only in lactating mammary gland it exceed 30% of the 
total [29]. 
  Promoter PI and PIII have been well characterized in 
sheep by previous researchers [29, 40, 42]. PI promoter re-
vealed the presence of one TATA box, two E-box motifs and 
a CAAT box motif. Analysis of the PI promoter using dele-
tion / mutation constructs, showed that the most close E-box 
motif to the transcription start site confer response to insulin. 
In this motif the transcription factors USF-1 and USF-2 were 
observed to bind, acting as an insulin-response sequence 
[40].  
  Concerning the PIII promoter, which is only observed in 
ruminant species [35, 40], it lacks both TATA and CCAAT 
boxes proximal to the transcription start site, having instead 
a sequence homologous to the inr sequence CTCANTCT, 
Table 1.  Main Characteristics of ACC-a Gene in Various Species 
Species  Chromosome Localization  Coding Exons  Amino Acids  Coding Sequence 
Homo sapiens  17q21 54  2346  245  Kb 
Mus musculus  11 54  2345  206  kb 
Rattus norvegicus  10q26 54  2345  195  Kb 
Ovis aries  11 ??*  2346  7401  bp 
Sus Scrofa (partial)  12p13 ??*  ??*  ??* 
Bus taurus  19q13 ??*  2346  ??* 
Gallus gallus  19 52  2324  >91.5  kb 
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found in a large number of TATA-less promoters [43]. Addi-
tionally, consensus sequences for binding a number of tran-
scription factors including two E-boxes, an inverted CCAAT 
box element (ICE) and a STAT motif were noted. Deletion 
analysis conducted in the promoter region showed that E-box 
and ICE results in a 75-95% reduction of the promoter activ-
ity. Moreover, SREBP-1 found to regulate the activity of 
PIII promoter between non-lactating and lactating mammary 
gland in a more extensive rate than that of USF-1, -2, and 
NFY transcription factors, which bind at the identified E-
boxes [42]. The STAT motif represents a sequence where the 
prolactin receptor can bind and confer response to stimuli 
concerning prolactin signalling. According to Mao et al. 
[44], in the bovine counterpart (PIII promoter) the STAT5 
transcription factor can bind to this site leading to an induc-
tion of promoter activity by prolactin and dexamethasone. 
Additionally, the PII promoter is also active in mammary 
gland and plays a crucial role for milk fat synthesis in sheep 
[45]. According to Barber et al. [28] the synergistic signaling 
between glucose and insulin increase the activity in PII pro-
moter and is depended on two Sp1 motifs that flank two 
SRE-half sites, where SREBP transcription facror (1a, 1c) 
can bind. These findings emerge the importance role of 
SREBP-1 in the regulation of the de novo synthesis of fatty 
acids in lactating mammary gland. Moioli et al. [46] reported 
three single nucleotide polymorphisms (SNPs) in the PIII 
promoter of ACC- gene in four Italian sheep breeds; Gen-
tile di Puglia, Sopravissana, Comissana and Sarda. The vari-
ant alleles that were identified were G1330T, C1338G and 
C1430T. Allele frequencies of Sarda breed found to differ 
significantly with respect to the other considered breeds. 
Association of such polymorphism with productivity traits 
would be a further implication. 
  Apart from the ovine ACC- gene, the goat counterpart 
has been also characterized. Travers and Barber [47] have 
reported the isolation of a partial cDNA clone (834 bp) cod-
ing the ACC- for goat. The isolated sequence, according to 
the authors, corresponds to about 11% of cDNA and re-
vealed over a 94% of amino acids identity with respect to rat 
and chicken counterpart. Recently, Badaoui et al. [48] re-
ported the molecular characterization of the goat counterpart. 
The sequence covers the 78% of the coding sequence and 
partially encompassed exons 3 to 46. The encoded protein 
shows over a 99% identity with its ovine and bovine 
orthologs. At transcriptional level, Travers and Barber [47] 
tried to assess the effects of different milking frequency on 
ACC gene expression in lactating goat mammary gland. The 
prolonged thrice daily milking found that produces a marked 
increase in the amount of ACC mRNA/mg DNA compared 
with a twice daily milking (41,0 ± 3,2 vs. 16,6 ± 6,5, P<0.01) 
indicating that increased ACC enzyme activity associated 
with the thrice daily milking is in part due to an increase in 
the abundance of the corresponding mRNA. Badaoui et al. 
[48] managed to identify a segregating silent single nucleo-
tide polymorphism (SNP) at exon 45 of goat ACC- gene 
(C5493T) in four Spanish breeds (Murciano-Granadina, 
Teramana, Majorera and Malaguena). Association of this 
SNP with milk traits showed that the specific C5493T muta-
tion is associated with fat yield, lactose content and somatic 
cell count.  
3.2. Fatty Acid Synthase (FAS) 
  Fatty acid synthase (FAS) is a key enzyme in the lipo-
genic pathway that catalyzes all the reactions involved in the 
last step of the fatty acid biosynthetic pathway and concerns 
the conversion of acetyl-CoA and malonyl-CoA to palmitic 
acid. FAS represents one of the more complex multifunc-
tional polypeptide structures discovered so far to date, be-
cause a single polypeptide contains all the catalytic compo-
nents required to a series of 37 sequential reactions, leading 
to the formation of palmitic acid. Much of the knowledge 
concerning FAS gene and its regulation comes from studies 
conducted on rodents, human and avian species [for review 
see 49, 50]. The gene has been cloned and characterized in 
rat [51], human [52], goose [53] and chicken [54]. 
  The enzyme in eukaryotes consists of two identical poly-
peptides of approximately 2,500 residues, it appears as ho-
modimer and each subunit has a molecular mass of 270 
KDa. The amino sequences show high identity among the 
characterized species which reach the 80%. The active en-
zyme is organized in a head to tail fashion, generating two 
active catalytic centers, containing seven catalytic activities 
and an acyl carrier protein (ACP) [52].  
  Concerning ruminant species, the only known data about 
FAS, is the recently cloned bovine counterpart [55]. The 
gene consists of 43 exons which together with the flanking 
regions were found to be evolutionary conserved. Moreover, 
at cDNA level in contrast to other characterized species, two 
transcripts were identified; one long form which consists of a 
7,542 bp coding region which encodes a protein of 2,513 aa 
residues, and a 358 bp shorter form, which derives from an 
alternative splicing of exon 9 resulting in a premature termi-
nation codon. Additionally, the gene maps to 19q22 chromo-
some region [56] and it is expressed higher in brain, testis 
and adipose tissue than in liver and heart. Although the bo-
vine FAS gene is expressed in all tissues, a different expres-
sion pattern of the two transcripts has been observed. FAS-1 
transcript is only detectable in tissues with the highest fatty 
acid synthesis in ruminants, leading to the suggestion that in 
tissues where both transcripts are observed FAS gene may be 
regulated by the ratio between the two transcripts. 
  The promoter region of the gene in ruminants consists of 
one TATA and CCAAT box with several potential binding 
sites for the nuclear transcription factor SP1 [57], following 
the same pattern as in rat [51]. However, in rat counterpart 
binding sites for fatty specific element (FSE), estrogen re-
sponse elements, thyroid hormone, growth hormone, proges-
terone and glycocorticoide response were observed. To our 
knowledge there is no such report for ruminants counterparts 
as similar studies have not yet conducted.  However, Roy   
et al. [57] observed a substitution of GC in the untrans-
lated exon 1 of the gene, altering the putative SP1 transcrip-
tion factor binding site and hence, leading to a less stable 
folding of the 5 UTR. Additionally, an AG substitution in 
exon 34, which leads to a replace of threonine by alanine, is 
associated with increased milk-fat content in Holstein-
Friesian cattles. Travers and Barber [47], using a heterolo-
gous (human) probe for FAS gene, managed to determine the 
effect of the prolonged daily milking in the expression of the 
goat counterpart mRNA. As they reported, the prolonged 
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amount of FAS mRNA/mg DNA compared with twice daily 
milking (114 ± 23 vs. 53,4 ± 14,3, P<0.01) and this paral-
leled the increase observed for FAS enzyme activity /mg 
DNA (774 ± 75 vs. 453 ± 85, P<0.01), indicating that the 
increased ACC enzyme activity associated with the thrice 
daily milking is in part due to an increase in the abundance 
of the corresponding mRNA. Although, these studies may 
offer new insights in the regulation of FAS gene, ovine and 
goat counterparts should be isolated and cloned in order to 
elucidate useful information about FAS gene and protein in 
small ruminants. 
3.3. Genes Encoding NADPH Generating Dehydro-
genases 
  Many studies have been conducted concerning NADP 
dependent dehydrogenases and their enzymatic reaction in 
different stimulus in various species [14, 24, 58-61]. Accord-
ing to Strutz and Rogdakis [58] the levels of NADPH gener-
ating dehydrogenases form a valuable criterion to assess the 
general lipogenic enzymatic activity in swine. Using this 
criterion, Rogdakis et al. [62] made it possible to develop an 
efficient selection program on backfat content in swine. 
Moreover, a synchronized enzymatic activity of the NADPH 
producing enzymes has been reported in ovine adipose tissue 
[14, 24] suggesting a possible use of these enzymes as bio-
chemical markers of fat deposition and a potential involved 
mechanism of control at molecular level. 
3.3.1. Glucose 6-Phosphate Dehydrogenase (G6PD) 
  Glucose 6-phosphate dehydrogenase is the rate-limiting 
enzyme of the pentose phosphate pathway, catalyzing the 
first committed reaction. It is responsible for the conversion 
of glucose 6-phosphate to 6-phosphogluconate reducing 
NADP to NADPH, which is further used in biochemical pro-
cedures of the cell such as the de novo fatty acid synthesis or 
the protection of cell against the oxidative damage via the 
diminish of reduced glutathione (GSH). The importance of 
the enzyme was elucidated when its enzyme activity was 
associated with deficient cases in human (for review see 62). 
Moreover, recently, Tien et al. [63] showed that suppression 
of G6PD activity led to diminished proliferation of several 
cell lines. Previous studies have, also, revealed elevated 
G6PD activities in malignant tissues in various tissues, sug-
gesting a correlation between G6PD and cancer. However, 
several epidemiology studies did not reveal any difference 
between G6PD-deficient and healthy patients, but it is true 
that deficient individuals may suffer from an increased risk 
of diabet and cataract.  
  The enzymatically active form of G6PD is either a dim-
mer or a tetramer of a single protein subunit of 514 amino 
acid residues with a molecular mass of 59,096 Da and con-
tains tightly bound NADPH for almost all the species [64]. 
Three are the critical regions for enzyme function which are 
also highly conserved in all higher mammals: i) the substrate 
binding site which is located near the Lys205 ii) the catalytic 
NADP binding site, which is located near the N-terminus 
and is important for its catalytic action and iii) the structural 
NADP binding site, which is important for the stability of 
the enzyme. At 3D-structural level the protein appears to 
form a classic dinucleotide binding fold and a domain fol-
lowing a + fold (Fig. 4), which is characteristic of all 
G6PD proteins analyzed so far.  
  At molecular level, G6PD has been well studied in many 
eutherian monogastric species. Complete characterized se-
quences have been already published for human, mouse and 
rat genes including promoter regions [65-69], while many 
studies have shown gene’s regulation in respect to various 
stimuli [for review see 70]. In all species studied so far 
G6PD is considered as an X-linked gene displaying a 
“housekeeping” profile [64, 70]. In human the gene spans 
18Kb containing 13 exons and maps on Xq28. Moreover, the 
number and the size of exons/introns and the sequence of 
exons are conserved in higher eukaryotes. The sequence 
identity between human G6PD cDNA and that of mice or 
rats reaches the 90%. The similarity between the mouse and 
the rat cDNA sequence is even higher (95% identity). It 
should be noted that the structure of the gene is unusual in 
that the second intron is too long (11 Kb in hunam) and ac-
counts for almost half the gene. The large size of second 
intron is also conserved between human, rat and mice. The 
promoter of G6PD embedded in a CpG island that is con-
served in higher eukaryotes. It also contains a TATA-like 
sequence (TTAAAT) and numerous stimulatory protein 1 
elements (SP1 sites), but no CAAT element. A wide number 
of mutations (over 140) have been found in the coding re-
gion of human coding region (single nucleotide mutations, 
small deletions, spliced mutations). In most cases these mu-
tations cause G6PD deficiency by decreasing the in vivo sta-
bility of the protein. Although Menousos et al. [71] tried to 
associate promoter G6PD mutations with deficient cases, no 
correlation was found.  
  Although in ruminants G6PD is one of the main suppliers 
of NADPH for the de novo synthesis of fatty acids, the only 
detailed study at molecular lever that has been reported is for 
the ovine counterpart [72, 73]. Interestingly, according to the 
authors, two cDNA transcripts, OG6PDA and OG6PDB, 
were detected encoding for two polypeptides of 515 and 524 
amino acid residues, respectively. The formation of 
OG6PDB transcript is a result of an alternative spliced ge-
nomic region originated at the last 31 bp of the intron 5 of 
the ovine G6PD gene. Both deduced amino acid sequences 
revealed a well conserved protein containing all the impor-
tant residues for its catalytic role. Ovine G6PD, like all oth-
ers G6PD proteins forms a classic dinucleotide binding fold 
and a domain following a + fold, containing all the appro-
priate functional motifs (Fig. 3). Additionally, the observed 
extra nine amino acids encoded by OG6PDB isoform cause a 
frame shift in the polypeptide chain resulting in changes 
around the area of the potential substrate binding sites. This 
frame shift, according to the ovine three-dimensioned model 
of G6PD, causes structural changes in the catalytic binding 
pocket of the molecule leading to a bigger binding pocket 
(Fig. 3). However, OG6PDB isoform contains all the appro-
priate residues for binding to substrate and catalysis and, 
thus, it is hypothesized that OG6PDB isoform could proba-
bly result in low glucose 6-phosphate dehydrogenase. The 
interesting is that although OG6PDA transcript showed to 
follow a “housekeeping” profile in ovine tissues, OG6PDB 
did not expressed in tissues of low importance for fatty acid 
synthesis in ruminants (liver, heart, cerebellum), indicating 
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may be regulated by the ratio between the two transcripts, 
depended on the existence stimulus. Additionally, previous 
studies of genetic linkage analysis using somatic cell hy-
bridization methods showed that ovine G6PD maps to Xq3.8 
[74-76] while it appears as a single copy gene in the sheep 
genome (Laliotis et al., 2007a). It is clear that the investiga-
tion of the physiological role of OG6PDB transcript would 
be of utmost importance in order to clarify the involvement 
of ovine G6PD gene in lipogenesis.  
  At transcription level, ovine G6PD promoter region has 
many conserved blocks in regard to the other known mam-
malian G6PD promoter regions [77]. Moreover, the charac-
terization of the region showed the presence of a TATA box, 
three GC boxes and several binding sites for SP1 and AP2 
transcription factors. Many other binding sites for transcrip-
tion factors involved in lipogenesis (SREBP, USF, RAR, 
RXR, ROR, HNF4) were also have noted within the 5’ regu-
latory region of ovine G6PD gene. It is worth mentioning 
that the most important regulatory elements of ovine G6PD 
gene (E box, GC box, SREBP, SP1, AP2) are conserved with 
respect to the human and rodents counterparts (Fig. 4). How-
ever, a slight variation in the number and the position of 
some of these motifs, such as SREBP, E-boxes and GC 
boxes, has been reported [77], indicating the first preliminary 
differences at transcription level of G6PD gene. This ob-
served variation may reflect a different mechanism in the 
response of ovine G6PD gene, according to various ‘exoge-
nous’ stimuli (i.e. diet rich in carbohydrates, insulin etc.). 
However, further studies are needed in order to elucidate in 
depth the roles of these motifs and to better understand the 
ruminant G6PD regulation and how it influences lipogenesis.  
3.3.2. 6-Phosphogluconate Dehydrogenase (6PGD) 
  The enzyme 6-phosphogluconate dehydrogenase is in-
volved in the third step of the pentose phosphate pathway. It 
catalyzes the oxidative decarboxylation of 6-
phosphogluconate to ribulose 5-phosphate, with the simulta-
neously release of CO2  and the reduction of NADP to 
NADPH [78]. 
  Eucaryotic 6PGDs are proteins of about 470 amino acids 
whose sequences are highly conserved. The enzyme is di-
meric and NADP dependent for almost all the species [79]. 
The subunit molecular weight found to be 52 KDa and only 
the crystal structure of ovine liver enzyme has been deter-
mined [80]. The functional importance of the enzyme is gen-
erally recognized in providing NADPH for fat synthesis and 
ribose for nucleic acid synthesis [81]. However, in the last 25 
years several studies elucidate the involvement of the en-
zyme in various human diseases. Thus, 6PGD deficiency has 
been referred, where the activity of the enzyme was reduced 
35% in the affected members of a family under investigation 
[82]. The 6PGD activity was found to be decreased in aged 
human erythrocyte populations, with the aged enzyme hav-
ing 11 fewer lysine residues than the young enzyme. Oxida-
tion of 6PGD may be also considered an important process 




















Fig. (3). Ovine G6PD protein model [72]. (A) Theoretical three-dimensional molecular model of ovine G6PD protein (left and centre figure) 
and human protein (right figure). The colored segments of the backbone structure mark the location of -helix (red), -sheet (green) and coil 
(white). (B) Structural representation of catalytic motif of OG6PDA isoform and human G6PD protein. (C) Structural representation of cata-
lytic motif of OG6PDB isoforms. Comparative Approach of the de novo Fatty Acid Synthesis  Current Genomics, 2010, Vol. 11, No. 3    175 
 The  amino  acid sequences of almost 40 different 6PGDs 
have been reported including human [84], mouse [85], rat 
[86] and pig [87] encoding a protein of 482 aa residues. The 
human 6GPD gene consists of 13 exons, while the size of the 
introns varies (Table 2). Introns near the 5’ and 3’ UTR are 
relative small compared with that existing through out the 
gene. Interestingly, the number, the position and the size of 
introns are highly conserved among human, mouse and rat. 
The amino acid sequence of 6GPD sequence is highly con-
served, over 85%, between the higher eucaryotes. Concern-
ing the chromosome map of the gene, it differs between the 
species analyzed so far. Specifically, human 6PGD maps to 
1p36.22, swine 6PGD to 6q22, while murine and rat coun-
terparts map to 4
th chromosome and 5q36, respectively. 
  In ruminants extensive studies have been reported only 
for sheep. Somers et al. [88] determined the amino acid se-
quence based upon the isolation of the cDNA clones encod-
ing the 6PGD gene in sheep, obtained by a PCR-based strat-
egy. Thus, the isolated cDNA encodes a protein sequence 
that is 482 amino acid residues long with a molecular mass 
of 52 KDa. The conservation of the protein sequence is very 
high as it shares an over 50% similarity with the protein en-
coded by the E. coli 6PGD gene and over 80% similarity 
with that of other mammals (human, rodents, pig). Addition-
ally, the ovine gene maps to the 12q2.2 chromosome region 
[74]. Preliminary studies of the genomic structure of ovine 
6PGD gene showed that at the 5’ genomic region, the size of 
introns and exons differed from that reported for human, 
mouse and rat counterparts, revealing different intron posi-
tions, in contrast with the 3’ genomic region, where the size 
and position was identical to these reported mammalian 
counterparts. Differentiation of introns / exons size and posi-
tion is possible related to differentiation in the role of 
6PGDH in mammals examined and diversification of the 
mechanisms related to 6PGDH gene expression [89]. 
  Analyzing in more depth the crystallographic structure 
studies [80, 90], is revealed the presence of a considerable 
amount of -helix (34 % vs. 4% -sheet). The molecule con-
sists of two domains separated by a “cleft” in which only the 
smaller domain contains any -structure. Binding studies 
with co-enzyme, coenzyme analogues and substrate [91] 
showed NADP to bind in the “cleft”, distant from the dim-
mer interface and to have a slightly less open conformation 
than that of NAD dehydrogenases (i.e. the lactate dehydro-
genase ternary complex) [92]. This is dissimilar to NADP-
binding sites observed in all other NADP dehydrogenases so 
far investigated [88].  
  Concerning the 5’ regulatory region, no sequential in-
formation is known so far to date, indicating the need of fur-
ther research. However, preliminary information can be ob-
tained about transcription of 6PGD gene through studies 
concerning the expression profile of the 6PGD gene during 
various productive stages of animals. 6PGD expression pro-
file has been studied in adipose tissue during lactation in two 
groups of ewes of Chios breed [89]; one with high yield 
(>1,7 Kg milk / day) and one with low yield (<1,1 Kg milk/ 



















Fig. (4). Comparative approach of the 5 regulatory region of G6PD gene between ruminant and non ruminant species. The most important 
motifs such as TATA box, E-box, GC-box, SREBP, SP1 (Stimulating Protein 1), AP1 (Activator Protein 1) and AP2 (Activator Protein 2) 
are present in the promoter region of the three mammals (sheep, human, mouse). However, some differences were noted. For example, AP1 
was only present in murine sequence, E-box 2 and 3 were conserved only in sheep and human regions, while a variation in the location of 
SREBP binding site was observed among the promoter region of the three analyzed mammals. 176    Current Genomics, 2010, Vol. 11, No. 3  Laliotis et al. 
higher in the low yield ewes with respect to that of high 
yield, where the expression was lower. Moreover, as lacta-
tion yield became higher, the expression profile of 6PGD 
gene became lower. This shows that the rate of lipogenesis 
in adipose tissue is diminished during lactation and with re-
spect to the increase of milk yield. 
3.3.3. Cytosolic NADP Malate Dehydrogenase/Malic En-
zyme 1 (ME1) 
  Malic enzyme (or malate dehydrogenase) catalyses the 
oxidative decarboxylation of malate to pyruvate using either 
NAD
+ or NADP as a cofactor. In mammalian tissues three 
distinct isoforms have been described; a mitochondrial 
NAD-isoform, and two NADP-dependent isoforms, a first 
localized in cytosol (ME1) and a second occurred in mito-
chondria (ME2). Cytosolic malic enzyme (ME1) or NADP-
malate dehydrogenase is considered to be a NADPH-donnor 
for fatty acid synthesis. Also it is involved in the supply of 
fatty acids with the essential acetyl-coA. As it has been 
aforementioned, glucose is catabolized to pyruvate and then 
to acetyl-coA. The last is produced in mitochondria but it is 
essential for fatty acids biosynthesis which takes place in 
cytosol [93]. Malic enzyme takes part in the reactions of 
pyruvate/citrate cycling and thus plays a role in the export of 
the acetyl-coA to the cytosol. In ruminants, contrary to hu-
mans and rodents, the pathway of glucose-pyruvate-acetyl-
coA is of little significance, as the principal carbon source 
for lipogenesis instead of glucose, is the acetic acid produced 
by the rumen’s microorganisms [94]. The expression of the 
enzyme is regulated by both hormones and nutrition. In par-
ticular, T3 and insulin stimulate malic enzyme in liver and 
adipose tissue while glucagon blocks this effect. Moreover, a 
high-carbohydrate low fat diet after a period of starvation 
results in an increased enzyme’s expression in liver and adi-
pose tissue. 
  The gene encoding ME1 has been well studied in many 
monogastric species, including human [95], mouse [96], rat 
[97] swine [98], duck [99] and pigeon [100] counterparts. 
The enzyme is a tetramer of four structurally identical 
subunits each of ~60 kDa. However, the complex appears to 
be bifunctional as only two of the active sites undergo turn-
over during catalysis [97]. 
  In sheep, unlike to other species, two transcripts encod-
ing ovine ME1 has been reported [101], which may further 
elucidate possible explanations for the minor role of cytoso-
lic malic enzyme in these species. The transcripts share the 
same CDS, but they differ in the length of 3’ UTR (Table 3), 
which is a result of a dual distinct polyadenylation signals. 
Such types of transcripts have been also reported for ME1 
murine [96] and swine [98] counterparts. Concerning the 5’ 
UTR, is common for the two transcripts and is also highly 
GC% rich, like in human and rodents. All deduced amino 
acids sequences analyzed so far today are highly conserved, 
showing an over 75% identity (Table 3), and revealing the 
important biological function of the enzyme in living organ-
isms.  
  Concerning the protein structure, two studies, based on 
crystal forms from pigeon [102] and rat [103] cytosolic 
NADP
+ malate dehydrogenase, have been reported. Accord-
ing to them, four major conserved regions are distinguished: 
a) the divalent cation binding residues b) the substrate bind-
ing residues, c) the NADP
+ cofactor binding residues and d) 
the catalytic residues. Crystal structure comparison of human 
NAD(P)
+-dependent malic enzyme and the pigeon cytosolic 
malic enzyme shoed that the backbone traces are similar with 
small local conformational differences, reflecting the struc-
tural basis of the different properties observed in the cataly-
sis of substrate or cofactors specificities [104]. Alignment of 
the cytosolic malic enzyme proteins of sheep and pigeon 
Table 2.  Intron and Exon Barriers in Human 6GPD Gene 
EXON Coding  EXON  INTRON 
coords length coords length  coords  length 
1 - 98  98 bp  91 - 98  8 bp  99 - 601  503 bp 
602 - 677  76 bp  602 - 677  76 bp  678 - 1365  688 bp 
1366 - 1545  180 bp  1366 - 1545  180 bp  1546 - 4043  2498 bp 
4044 - 4109  66 bp  4044 - 4109  66 bp  4110 - 5133  1024 bp 
5134 - 5252  119 bp  5134 - 5252  119 bp  5253 - 9043  3791 bp 
9044 - 9113  70 bp  9044 - 9113  70 bp  9114 - 12390  3277 bp 
12391 - 12525  135 bp  12391 - 12525  135 bp  12526 - 14034  1509 bp 
14035 - 14224  190 bp  14035 - 14224  190 bp  14225 - 17959  3735 bp 
17960 - 18090  131 bp  17960 - 18090  131 bp  18091 - 18348  258 bp 
18349 - 18482  134 bp  18349 - 18482  134 bp  18483 - 19798  1316 bp 
19799 - 19898  100 bp  19799 - 19898  100 bp  19899 - 20389  491 bp 
20390 - 20512  123 bp  20390 - 20512  123 bp  20513 - 20602  90 bp 
20603 - 21117  515 bp  20603 - 20722  120 bp     Comparative Approach of the de novo Fatty Acid Synthesis  Current Genomics, 2010, Vol. 11, No. 3    177 
revealed that the overall structure of the proteins is similar 
[101]. 
  At transcription level, available information concerns the 
human, rat and ovine promoter region. The molecular clon-
ing and functional characterization of the human ME1 pro-
moter region showed that the region is GC rich, it has multi-
ple transcription start sites and lacks of TATA or CCAAT 
boxes [105]. Similar characteristics have been reported for 
the rat counterpart [106]. The presence of an inverted T3 
response element (TRE), where thyroid receptor beta 
(TRbeta) can bind in the absence of T3 in human ME1 pro-
moter, represses its promoter activity, revealing that ME1 
transcription is very responsive to thyroid hormones.  
  Concerning the ovine ME1 promoter, the same major 
characteristics as in other species are reported. It is located 
within a GC-rich region and lacks a TATA-box. According 
to deletion analysis, a region (231/170) that suppressed 
promoter activity in luciferase assays in HepG2 hepatoma 
cells but not in 3T3-L1 adipocytes was identified. This re-
gion contains a putative triiodothyronine response element 
(T3RE) that differs from the human ME1 T3RE by two nu-
cleotides. When the human ME1 T3RE was introduced into 
the ovine ME1 promoter context, transcriptional activity was 
increased in the hepatic cell lines HepG2 and H4IIE but not 
in differentiated 3T3-L1 cells. These results suggest that the 
sequence of the T3RE in the ME1 promoter determines dif-
ferences in the tissue/species activity of malic enzyme in 
ruminants and human [107]. This functional difference may 
be related to the differential contribution of liver and adipose 
tissue in whole body lipogenesis between humans and sheep 
as a ruminant species. However, further studies should be 
conducted in order to support this hypothesis.  
3.3.4. Cytosolic NADP Isocitrate Dehydrogenase (IDH1) 
  Three distinct forms of the enzyme have been found in 
mammalian organisms including the NAD
+ dependent IDH, 
which is located exclusively in the mitochondria, and two 
NADP-dependent IDH which are found in mitochondria 
(IDH2) and in cytosol (IDH1), respectively [108-110]. The 
mitochonrial NAD
+-dependent isocitrate dehydrogenase 
catalyzes the oxidative decarboxylation of isocitrate in the 
tricarboxylic acid cycle, while IDH1 and IDH2 are responsi-
ble for the generation of a-ketoglutarate, CO2, and NADPH 
from isocitrate in the cytosol and mitochondria, respectively. 
NADPH produced in the cytosol is the primary source, as it 
has been noted, of reducing equivalents utilized for fatty acid 
synthesis both in ruminants and non ruminant species. 
  IDH isoforms are encoded by different nuclear genes 
[111,112] and sequence analysis revealed high levels of ho-
mology and amino acid sequence conservation throughout 
the respective mammalian counterparts [113]. To date, 
mammalian cDNAs coding for IDH1 (cytosolic) have been 
isolated from rat [109], mouse [114] and human [113]. Con-
cerning the subgroup of ruminants, the complete character-
ized sequence has been elucidated for the cattle counterpart 
[115], while in small ruminants only the ovine cDNA has 
been cloned and characterized [116].  
  Ovine IDH1 cDNA is 2,254 bp long and it consists of 
166 nt 5’ UTR, 1,245 nt coding region, 843 nt 3’ UTR and 
poly A tail [116]. It is worth of mentioning that no profound 
polyadenylation signals has been found on the ovine IDH1 
sequence, which coincides with the observation of Nek-
rutenko et al. [113] for all the isolated mammalian counter-
parts. Concerning the deduced protein sequence of ovine 
IDH1, it consists of 414 amino acid residues, like all other 
known mammalian counterparts, and has a predicted mo-
lecular mass of 46.8 KDa. Moreover, comparison with the all 
known IDH1 amino acid sequences revealed a well con-
served protein throughout evolution. To our knowledge, up 
to date no extensively study concerning the protein structure 
of IDH1 has been reported. However, IDH1 gene is present 
in the ovine genome as a single copy gene, while it maps to 
the 2q3.4 chromosome region [76], showing a chromosome 
conservation between the mammalian species. 
 Kenoutis  et al. [116] examined the expression pattern of 
IDH1 in the adipose tissue of growing Chios breed lambs of 
both sexes, fed with a diet rich in carbohydrate and slaugh-
tered in three different body weights (25 kg, 30 kg and 35 
kg). According to the authors, differences in the IDH1 gene 
expression between male and female animals of the same 
body weight, animals of different body weight and between 
fat depositions in the body of the same animal were ob-
served. In males, the expression levels of IDH1 gene in peri-
renal adipose tissue were higher than those observed in tail 
and lateral adipose tissue at the weight of 25 kg. As the 
bodyweight increased, expression became more distinctive. 
Moreover, lateral adipose tissue demonstrated the highest 
IDH1 mRNA abundance among the three examined tissues. 
In contrast, in female lambs, at the body weight of 25 kg, the 
highest abundance was detected in tail adipose tissue, 
whereas, as the body weight was increasing, in perirenal 
adipose tissue.  
  At transcription level, to our knowledge so far to date no 
sequential information is available for the 5’ regulatory re-
gion of IDH1 gene is ruminants. However, extensive studies 
Table 3.  Structure of Ovine Malic Enzyme 1 and Differences between Species 
Similarity 
ME 1  Full length  Coding sequence  5’ UTR  3’ UTR 
species   CDS  protein 
human 90% 96% 
Transcript 1  2121 bp  346 bp 
swine 91%  97% 
rodents 84% 93% 
Transcript 2  3243 bp 
1716 bp / 571 a.a.  58 bp 
1469 bp 
chicken 77%  78% 178    Current Genomics, 2010, Vol. 11, No. 3  Laliotis et al. 
have been conducted in the human counterpart. Human 
IDH1 gene transcription is sterol regulated and its promoter 
region contains a SRE-sequence element, which is a poten-
tial binding site for the SREBP transcription factors. Analy-
sis based on promoter reporter gene, showed that IDH1 pro-
moter is fully activated by SREBP1 and to a lesser extent by 
SREBP2, while the presence of a CAAT and a GC- box can 
result in a 6.5% residual activity (Shechter et al., 2003). 
Based on these data, further studies can been conducted on 
the identification and characterization of the promoter region 
of ovine, goat or bovine IDH1 gene, in order to clarify the 
transcription regulation of the gene in ruminants. 
4. TRANSCRIPTION REGULATION OF THE LIPO-
GENIC GENES 
  The first step of gene expression and the primary step at 
which gene expression is controlled is transcription. This is 
succeeded through the recruitment of several transcription 
factors, which have the ability to bind on certain target-
sequences, primarily located in the 5’ upstream regulatory 
region of the genes, and promote or suppress gene transcrip-
tion according to the stimulus (i.e. nutrients, hormones etc.). 
Much of the data concerning the control of lipogenic genes 
at transcriptional level comes from monogastric animals and 
especially rodents. To our knowledge this field has not yet 
be clarified in ruminants. However, in this section we would 
try to briefly review major data from non ruminant species in 
order to create a more spherical view about the transcription 
regulation of lipogenesis. 
  SREBPs comprise one of the most important transcrip-
tion factors that can mediate the expression of lipogenic 
genes. They belong to a large class of transcription factors 
containing basic helix loop helix (bHLH)-Zip domains. Un-
like other members of this class, SREBPs are synthesized as 
membrane bound precursors that require cleavage by a two 
proteolytic process in order to release their amino-terminal 
bHLH-Zip domain into the nucleus to bind to a specific 
DNA sequence and to activate their target genes in a sterol 
regulated manner. Moreover, they can be divided into three 
types: SREBP-2, SREBP-1a and SREBP-1c. The last two are 
product of a single gene through the use of alternative pro-
moters, in contrast with the former that is encoded by a sepa-
rated gene. Moreover, SREBP-2 is associated with genes 
involved in cholesterol metabolism (i.e. LDL-receptor, far-
nesyl diphosphate synthase, squalene synthase etc.), while 
SREBP-1 is involved in the regulation of the lipogenic genes 
such as ACC, FAS, G6PD etc. [for review see 117, 118]. In 
addition, SREBP-1c regulates direct the lipid homeostasis by 
activating lipogenic genes including FAS and ACCa genes, 
which are involved in the production of palmitate. Binding 
of SREBPs to DNA leads to the recruitment of co-activators 
such as CBP. However, SREBP-1c has been reported not to 
strongly interact with co-factors. SREBPs can bind DNA as 
dimmers at sterol regulatory elements (SREs), which are 
typically located very near binding sites for SP1 and/or NF-
Y. Moreover, in the majority of promoters, these other ele-
ments play an important role in SREBPs function. Thus, 
SREBPs functionally interact with these additional transcrip-
tion factors to elevate transcription of the cis-linked genes 
[118]. The induction of lipogenic genes by insulin and glu-
cose is mediated via the action of SREBP-1. This is clearly 
displayed through the protocol of fasting/refeeding. SREBP-
1 can down regulate gene expression when a deprivation of 
food is applied and the level of insulin is low, while on the 
other hand it can enhance gene expression when rodents are 
placed on a high carbohydrate diet. In contrast with glucose 
and insulin, when a diet rich in polyunsaturated fatty acids is 
fed, a down regulation of lipogenic gene expression is ob-
served via the recruitment of SREBP-1 [119-124].  
  The presence of E-box motifs in the promoter region of 
lipogenic genes is of particular importance. This motif 
(CANNTG) can confer carbohydrate, glucose or insulin re-
sponse sensitivity [125-127] especially through the binding 
of SREBP and USF transcription factors on this motif. Ac-
cording to Arkwright-Keeler and Stapleton [128], mutations 
caused in the unique E-box existing in rat G6PD promoter 
resulted in significantly reduce of glucose and insulin re-
sponse. Additionally, the same authors demonstrated that an 
USF transcription factor which binds to this motif, is in-
volved in the response of G6PD to a high carbohydrate diet. 
Moreover, mutations that weaken binding of USF-1 and 
USF-2 to E-box motif, abolish the insulin dependent activa-
tion of the fatty acid synthase promoter [122]. Casado et al. 
[129] using mice lacking USF-1 or/and USF-2 showed the 
importance of these transcription factors in mediating the 
stimulatory effect of insulin/glucose on fatty acid synthase 
expression. In addition to the E-box motif, the carbohydrate 
response transcription factor (ChoRF) can also confer re-
sponse to glucose stimulus. Its binding site is appeared as a 
combination of two E-box represented by the palidromic 
sequence CANNTGn5CANNTG and it has been observed in 
the promoter regions of many lipogenic genes such as fatty 
acid synthase, pyruvate kinase or S14 gene. According to 
Rufo et al. [130], the ChoRF appears to work in conjunction 
with SREBP-1c and USF to impart glucose and insulin re-
sponsiveness to the fatty acid synthase promoter. 
  Additionally, much discussion has been made about the 
PPAR transcription factor and its impact on the regulation 
of lipogenic genes. It should be noted that this transcription 
factor is part of the adipocyte differentiation program con-
cerning the field of adipogenesis [for review see 131, 132] 
and it has little to be associated with the regulation of lipo-
genesis. However, according to Kersten [122] patients who 
took synthetic PPAR activators frequently gain weight, 
something which implies that PPAR apart from adipogenic 
effect can also have a lipogenic effect. In addition, PPARs, 
are considered as monitors of the oxidized lipids, as fatty 
acids are feed-forward regulators of PPARs. However, 
PPAR activation leads to the induction of many genes in-
volved in fatty acid oxidation or fatty acid storage [118]. 
Recently, much ground on the transcription regulation of 
lipogenic genes have gained some members of the nuclear 
receptor family such as RAR, RXR, ROR and HNF4. Nu-
clear receptors function as ligand-activated transcription fac-
tors that regulate the expression of target genes to affect 
various processes. These transcription factors have been re-
ported to modulate and control the transcription of genes 
involved in lipogenesis, causing activation or repression of 
transcription [133-136]. They can bind on the recognition 
site either as homodimers or heterodimers, i.e. RAR/RXR 
influencing the transcriptional control of the lipid-sensing 
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can act in a more indirect way, favoring or not the presence 
of other regulatory proteins which control the transcription 
regulation of lipogenesis. For instance, RXRa and HNF4 
favor the presence of SREBP-1c resulting in up- or down- 
regulation of lipogenic genes [136]. 
  It is clear that although many mechanisms controlling the 
transcription regulation of lipogenesis has been fully or par-
tially elucidated, much data, especially concerning rumi-
nants, has to be clarified. As ruminants demonstrate certain 
differences with regard to fatty acid synthesis and lipogene-
sis, implicating a potential different way of controlling the 
genes involved in this procedure, further investigation on 
transcription regulation of lipogenic genes in ruminants, may 
offer new insights in this type of control. 
WHAT CAN BE DONE IN THE FUTURE? 
  Undoubtedly, years of intensive study in mammalian 
species have definitely identified several key pathways and 
molecules that are involved in the regulation of the de novo 
synthesis of fatty acids. Many advances have also been con-
ducted in ruminants revealing the differentiation of some 
aspects in comparison to other mammalian species with re-
spect to lipogenesis. The application of molecular biology 
elucidated many unexpected complexities, such as multiple 
promoters, different isoforms of enzymes (G6PD, FAS, ace-
tyl-CoA carboxylase, malic enzyme) and many single nu-
cleotides mutations. Despite these advances, there are still 
many questions that remain unsolved, ranging from the asso-
ciation of single nucleotide mutations with productivity traits 
to the very challenging aspect of manipulating lipogenesis.  
  Investigation of the observed mutations at DNA level and 
their association with productivity traits i.e. milk fat content, 
carcass quality/marbling, would be a first approach in ma-
nipulating lipogenesis in farm animals. This association can 
further be used in selective breeding schemes so that new 
lines with the desired characteristics, such as less fat content, 
could be achieved. In addition, the discover of novel muta-
tions on DNA level may also reveal new mechanisms of 
transcript regulation.  Moreover, the elucidation of the 
physiological role of new identified transcripts of genes i.e. 
ovine G6PDB transcript or ovine ME1 transcripts that are 
involved in lipogenesis in ruminants and are not found in 
other species, is of particular importance as they may offer 
novel data in the mechanisms of regulation of the de novo 
synthesis of fatty acids according to various stimuli in com-
parison to human and rodents.  
  Additionally, identification of common regulators of 
lipogenic genes could offer new prospects. A working model 
of this aspect could be the “platform” of genes encoding 
NADPH generating dehydrogenases. Specifically, previous 
studies [14, 24] report a synchronized enzymatic activity of 
the NADPH producing enzymes in ovine adipose tissue. 
This observed synergic action of the mentioned dehydro-
genases may be due to involved mechanisms at transcrip-
tional level, using a common regulator. The identification of 
such a mechanism may probably permit the control of lipo-
genesis in specific tissues. For example, interfering in such a 
mechanism using i.e. an inhibitor, can lead to the reduction 
of mRNA coding for the respective lipogenic enzymes and 
hence could lead to a tissue specific reduction in the amount 
of lipogenic proteins and a diminution in fatty acid synthetic 
capacity.  
  Transgenesis may be offer many advances in the field of 
lipogenesis as it is considered a potential experimental ap-
proach for investigating both the control of the de novo syn-
thesis of fatty acids and for modulating the improvement of 
animal performance. Such case studies have been limited in 
rodents. For example, in mice lacking lipoprotein lipase fatty 
acid composition of adipose tissue lipids indicated a com-
pensatory increase in de novo fatty acid synthesis [137]. To 
our knowledge, transgenic animals concerning the main 
lipogenic genes have not been reported. However, Ha and 
Kim [133] reported the production of an adipocyte cell-line 
in which the amount of ACC was reduced using a ribozyme 
construct resulting in a decreased rate of fatty acid synthesis. 
Despite the fact that in ruminants no transgenic effort has 
been conducted, the development of proper adipocyte cell 
lines, where in vitro studies can be conducted, would be an 
advantage compensating the large generation interval ob-
served in ruminants in contrast with rodents. 
ABBREVIATIONS 
aa =  Amino  acids 
ACC =  Acetyl-CoA  carboxylase 
bp =  Base  pair 
cDNA  =  Complementary to RNA 
CDS =  Coding  sequence 
G6PD  =  Glucose 6-phosphate dehydrogenase 
FAS =  Fatty  acid  synthase 
IDH =  Isocitrate  dehydrogenase 
6PGD =  6-phosphogluconate  dehydrogenase 
kDa =  Kilodalton 
ME =  Malic  enzyme 
NADP  =  Nicotinamide adenine dinucleotide phosphate 
NADPH = Reduced nicotinamide adenine dinucleotide 
phosphate 
nt =  Nucleotide 
PCR  =  Polymerase chain reaction. 
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